VISLARAFUSP ALFA
UNII GTN7CK8Y7C

Substance Identification & Data

This profile provides standardized clinical and technical data for Vislarafusp Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GTN7CK8Y7C.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2850355-96-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GTN7CK8Y7C

CAS Registry Number

2850355-96-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VISLARAFUSP ALFA

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C185132

National Cancer Institute reference terminology for clinical and research data.

INN ID

12965

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vislarafusp Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

GAMMA 1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV3-66*01 -(IGHD) -IGHJ4*01, CDR-KABAT (5.17.11) (31-35.50-66.99-109)) (1-120) -HOMO SAPIENS IGHG1*03 (CH1 (121-218), HINGE (219-233), CH2 S301>A, E336>A, K337>A (234-343), CH3 (344-448), CHS (449-450)) (121-450)), (223-354')-DISULFIDE WITH HUMAN SIGNAL REGULATORY PROTEIN ALPHA (SIRP ALPHA VARIANT V2 EXTRACELLULAR D1 DOMAIN, SIRP ALPHA V2D1) FRAGMENT (1-125), COMPRISING THE FIRST TWO EXTRACELLULAR LOOPS OF THE D1 DOMAIN, ENGINEERED VARIANT (N80>A)-VARIANT, ANTI-(HUMAN CD47, INTEGRIN ASSOCIATED PROTEIN (IAP)) (1-125 IN THE CURRENT SEQUENCE) FUSED VIA A (G4S)3PEPTIDE LINKER (126-140) TO KAPPA LIGHT CHAIN (141'-354') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 -IGKJ1*01, CDR-KABAT (11.7.9) (164'-174'.190'-196'.229'-237')) (141'-247') -HOMO SAPIENS IGKC*01 (248'-354')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

HUMAN SIGNAL REGULATORY PROTEIN ALPHA (SIRP.ALPHA.) FRAGMENT, ANTI-(HUMAN CD47, INTEGRIN ASSOCIATED PROTEIN (IAP)), FUSED VIA A (G4S)3 PEPTIDE LINKER TO THE N-TERMINUS OF BOTH LIGHT CHAINS OF A HUMANIZED IMMUNOGLOBULIN G1-KAPPA ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2), GLYCOFORM ALFA

IMMUNOGLOBULIN G1 (351-ALANINE,386-ALANINE,387-ALANINE) ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL IMM2902 .GAMMA.1-CHAIN), DISULFIDE WITH 1-125-SIGNAL REGULATORY PROTEIN .ALPHA. (80-ALANINE) (HUMAN ISOFORM 4 VARIANT) FUSION PROTEIN WITH PEPTIDE LINKER ((GGGGS)3) FUSION PROTEIN WITH HUMAN-MUS MUSCULUS MONOCLONAL IMM2902 .KAPPA.-CHAIN, DIMER

VISLARAFUSP ALFA

VISLARAFUSP ALFA [INN]